Therapeutically, BMP9 has been explored in PAH due to its ability to enhance BMPR2 signaling.17 However, its effects are highly context-dependent, with evidence for both protective and pathological roles, including EndMT induction in PAH MVECs. Here, BMPR2 is linked to pulmonary arterial hypertension.